THC logo

Tenet Healthcare (THC)

Profile

Full Name

Tenet Healthcare Corporation

Ticker Symbol

THC

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

March 17, 1980

Indexes

Not included

Website

http://www.tenethealth.com

Employees

74480

Key Details

Price

$122.92(-0.70%)

Market cap

Last Dividend

$0.03

TTM Dividend yield

-

Annual revenue

$20.66B(+0.57% YoY)

Annual EPS

$32.70(+472.68% YoY)

PE ratio

3.81

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$122.92
THC price is $122.92

30-Day Relative Volume

1.00
THC 30-day relative volume is 1.00

Price Performance

Price Today change

-0.7%
THC price is down -0.7% today

Price YTD change

-2.62%
THC price is down -2.62% since January 1st

Price 1-year change

+22.39%
THC price is up +22.39% year-on-year

Price 3-year change

+44.62%
THC price is up +44.62% over the past 3 years

Price Range

Price All-time high

$210.00
THC price is currently -41.46% below its historical high of $210.00

Price 3-year low

$36.69
THC price is currently +235.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.69B
THC market capitalization is $11.69 billion

Market cap 3-year change

+27.74%
THC market capitalization is up +27.74% over the past 3 years

Market cap All-time high

$25.46B
THC market capitalization is currently -54.07% below its historical high of $25.46 billion

Market cap sector rank

93.76%
THC market capitalization is higher than 93.76% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.61%
THC shares outstanding is down -2.61% year-on-year

Shares Outstanding 3-Year Change

-11.67%
THC shares outstanding is down -11.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
THC beta is 0.79

200-day SMA

$143.25
THC price is currently -14.19% below its 200-day simple moving average

50-day SMA

$130.63
THC price is currently -5.90% below its 50-day simple moving average

RSI

45.16
THC 14-day relative strength index is 45.16

Volume

1.00
THC 30-day relative volume is 1.00

ATR

$7.52
THC average true range is $7.52

10-day Historical Volatility

77.46%
THC 10-day historical volatility is 77.46%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.03
THC last dividend was $0.03 per share, with an ex-dividend date of March 13, 2000

Next Dividend

-
THC next dividend has not yet been announced

Dividend per share

Dividend per share

-
THC annual dividend per share value is unknown

Dividend per share Sector Rank

-
THC annual dividend per share is unknown

Dividend per share 1-Year Change

-
THC annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
THC annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
THC annual dividend yield value is unknown

Dividend yield Sector Rank

-
THC annual dividend yield is unknown

Other

Payout ratio

-
THC annual payout ratio value is unknown

Dividends paid

-
THC annual dividends paid value is unknown

Free cash flow

$1.12B
THC annual free cash flow is $1.12 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.66B
THC annual revenue is $20.66 billion

Revenue Analysts estimate

$20.89B
THC annual revenue is currently -1.10% lower than the consensus analysts' forecast

Revenue 1-year change

+0.57%
THC annual revenue is up +0.57% year-on-year

Revenue Sector rank

96.42%
THC annual revenue is higher than 96.42% of companies in Healthcare sector

EPS

EPS

$32.70
THC annual earnings per share is $32.70

EPS Analysts estimate

$12.09
THC annual earnings per share is currently +170.37% higher than the consensus analysts' forecast

EPS 1-year change

+472.68%
THC annual earnings per share is up +472.68% year-on-year

EPS Sector rank

99.67%
THC annual earnings per share is higher than 99.67% of companies in Healthcare sector

Profit

Gross profit

$17.02B
THC annual gross profit is $17.02 billion

Gross margin

82.35%
THC annual gross profit margin is 82.35%

Operating profit

$2.92B
THC annual operating income is $2.92 billion

Operating margin

14.12%
THC annual operating profit margin is 14.12%

Net income

$3.20B
THC annual net profit is $3.20 billion

Net margin

15.49%
THC annual net profit margin is 15.49%

Expenses

Total expenses

$17.75B
THC annual total expenses is $17.75 billion

Operating expenses

$14.10B
THC annual total operating expenses is $14.10 billion

Cost of goods sold

$3.65B
THC annual cost of goods sold is $3.65 billion

Selling, general & administrative expenses

$8.80B
THC annual SGA is $8.80 billion

Depreciation and amortization

$818.00M
THC annual depreciation & amortization is $818.00 million

Interest expense

$826.00M
THC annual interest expense is $826.00 million

Income tax

$1.18B
THC annual income tax is $1.18 billion

EBIT & EBITDA

EBIT

$6.07B
THC annual earnings before interest & taxes is $6.07 billion

EBITDA

$6.89B
THC annual EBITDA is $6.89 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$28.94B
THC annual total assets is $28.94 billion

Non current assets

$21.25B
THC annual long term assets is $21.25 billion

Current assets

$7.68B
THC annual total current assets is $7.68 billion

Cash and cash equivalents

$3.02B
THC annual cash & cash equivalents is $3.02 billion

Accounts receivable

$2.54B
THC annual accounts receivable is $2.54 billion

Inventory

$346.00M
THC annual inventory is $346.00 million

Liabilities

Total liabilities

$20.39B
THC annual total liabilities is $20.39 billion

Long term liabilities

$16.08B
THC annual total long term liabilities is $16.08 billion

Current liabilities

$4.31B
THC annual total current liabilities is $4.31 billion

Accounts payable

$1.29B
THC annual accounts payable is $1.29 billion

Debt

Total debt

$13.17B
THC annual total debt is $13.17 billion

Total debt 1-year change

-12.19%
THC annual total debt is down -12.19% year-on-year

Long term debt

$13.08B
THC annual long term debt is $13.08 billion

Short term debt

$92.00M
THC annual short term debt is $92.00 million

Equity & Capital

Shareholders equity

$4.17B
THC annual stockholders equity is $4.17 billion

Book value

$4.17B
THC annual book value is $4.17 billion

Retained earnings

$3.01B
THC annual retained earnings is $3.01 billion

Working capital

$3.37B
THC annual working capital is $3.37 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.05B
THC annual cash flow from operations is $2.05 billion

Cash from operations 1-year change

-13.77%
THC annual cash flow from operations is down -13.77% year-on-year

Cash from investing

$3.43B
THC annual cash flow from investing activities is $3.43 billion

Cash from investing 1-year change

+453.87%
THC annual cash flow from investing activities is up +453.87% year-on-year

Cash from financing

-$3.69B
THC annual cash flow from financing activities is -$3.69 billion

Cash from financing 1-year change

-256.04%
THC annual cash flow from financing activities is down -256.04% year-on-year

CAPEX

CAPEX

$931.00M
THC annual capital expenditures is $931.00 million

CAPEX 1-year change

+23.97%
THC annual capital expenditures is up +23.97% year-on-year

Free Cash Flow

Free cash flow

$1.12B
THC annual free cash flow is $1.12 billion

Free cash flow 1-year change

-31.24%
THC annual free cash flow is down -31.24% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

82.35%
THC annual gross profit margin is 82.35%

Operating margin

14.12%
THC annual operating profit margin is 14.12%

Net margin

15.49%
THC annual net profit margin is 15.49%

ROA & ROE

ROA

11.18%
THC annual return on assets is 11.18%

ROE

45.54%
THC annual return on equity is 45.54%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

3.81
THC price to earnings ratio is 3.81

PE ratio Sector rank

5.88%
THC price to earnings ratio is higher than 5.88% of companies in Healthcare sector

PB Ratio

PB ratio

2.80
THC price to book ratio is 2.80

PB ratio Sector rank

71.13%
THC price to book ratio is higher than 71.13% of companies in Healthcare sector

PS Ratio

PS ratio

0.57
THC price to sales ratio is 0.57

PS ratio Sector rank

18.85%
THC price to sales ratio is higher than 18.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$21.85B
THC enterprise value is $21.85 billion

Enterprise value Sector rank

95.13%
THC enterprise value is higher than 95.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.17
THC EV/EBITDA is 3.17

EV/EBITDA Sector rank

76.98%
THC EV/EBITDA is higher than 76.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.78
THC annual current ratio is 1.78

Quick ratio

1.70
THC annual quick ratio is 1.70

Leverage

Debt to equity

3.16
THC annual debt to equity ratio is 3.16

Interest coverage ratio

7.35
THC annual interest coverage ratio is 7.35

Risk & Stability

Piotroski F-Score

6
THC piotroski f-score is 6

Altman Z-Score

2.04
THC altman z-score is 2.04

Analyst ratings

Recent major analysts updates

Apr 9, 25 Guggenheim
Buy
Mar 26, 25 Morgan Stanley
Overweight
Feb 13, 25 Cantor Fitzgerald
Overweight
Feb 13, 25 Barclays
Overweight
Jan 7, 25 Keybanc
Overweight
Jan 6, 25 Truist Securities
Buy
Dec 16, 24 Goldman Sachs
Neutral
Nov 25, 24 Wells Fargo
Equal-Weight
Nov 22, 24 Raymond James
Outperform
Nov 8, 24 Barclays
Overweight

Institutional Ownership

Similar stocks

ILMN logo
Illumina (ILMN)
ICLR logo
ICON Public Limited (ICLR)
GMAB logo
Genmab A/S (GMAB)
ALGN logo
Align Technology (ALGN)
SOLV logo
Solventum (SOLV)
UHS logo
Universal Health Services (UHS)
RVTY logo
Revvity (RVTY)
SNN logo
Smith & Nephew (SNN)
INSM logo
Insmed Incorporated (INSM)
  • What is the ticker symbol for Tenet Healthcare?
  • Does Tenet Healthcare pay dividends?
  • What sector is Tenet Healthcare in?
  • What industry is Tenet Healthcare in?
  • What country is Tenet Healthcare based in?
  • When did Tenet Healthcare go public?
  • Is Tenet Healthcare in the S&P 500?
  • Is Tenet Healthcare in the NASDAQ 100?
  • Is Tenet Healthcare in the Dow Jones?
  • When was Tenet Healthcare's last earnings report?
  • When does Tenet Healthcare report earnings?
  • Should I buy Tenet Healthcare stock now?

What is the ticker symbol for Tenet Healthcare?

The ticker symbol for Tenet Healthcare is NYSE:THC

Does Tenet Healthcare pay dividends?

No, Tenet Healthcare does not pay dividends

What sector is Tenet Healthcare in?

Tenet Healthcare is in the Healthcare sector

What industry is Tenet Healthcare in?

Tenet Healthcare is in the Medical Care Facilities industry

What country is Tenet Healthcare based in?

Tenet Healthcare is headquartered in United States

When did Tenet Healthcare go public?

Tenet Healthcare's initial public offering (IPO) was on March 17, 1980

Is Tenet Healthcare in the S&P 500?

No, Tenet Healthcare is not included in the S&P 500 index

Is Tenet Healthcare in the NASDAQ 100?

No, Tenet Healthcare is not included in the NASDAQ 100 index

Is Tenet Healthcare in the Dow Jones?

No, Tenet Healthcare is not included in the Dow Jones index

When was Tenet Healthcare's last earnings report?

Tenet Healthcare's most recent earnings report was on Feb 12, 2025

When does Tenet Healthcare report earnings?

The next expected earnings date for Tenet Healthcare is Apr 29, 2025

Should I buy Tenet Healthcare stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page